Press releases

  • NOVEMBER 20, 2012

Roche, Fondation FondaMental and Inserm partners to improve understanding of autism mechanims.

Download (in French)pdf

  • NOVEMBER 12, 2012

Imagine Institute, GlaxoSmithKline (GSK) and Inserm Transfert Agree on a Collaborative Partnership for Drug Discovery for rare diseases.

Downloadpdf

  • OCTOBER 16, 2012

DBV Technologies and Centre d'Immunologie de Marseille-Luminy (CIML) enter in a Collaboration Agreement.

Downloadpdf

  • SEPTEMBER 19, 2012

Launch of ENTENTE, the first European network to boost knowledge transfer activity in health research in academic and governmental organisations and industry-academia collaboration.

Downloadpdf

  • JUNE 5, 2012

Sebia partners with Inserm and Inserm Transfert to develop a unique diagnostic test for haemoglobin diseases.

Downloadpdf

  • APRIL 11, 2012

The CKD-REIN cohort, funded under the "Investissements d'avenir" programme, brings together a partnership between 6 key industrials actors in the field of nephrology.

Download (in french)pdf

  • APRIL 4, 2012

Roche, the French National Agency for Research on AIDS and Viral Hepatitis, Baylor Research Institute and Inserm Transfert establish strategic collaboration to develop therapeutic vaccines for chronic infectious diseases.

Downloadpdf

  • JANUARY 12, 2012

"Investments for the future" programme: Fonds National d'Amorçage's first investment is in Inserm Transfert Initiative, a seed company specialising in life sciences and healthcare.

Downloadpdf

  • JANUARY 12, 2012

Covance Inc. (NYSE: CVD), the French National Institute of Health and Medical Research (Inserm) subsidiary Inserm Transfert SA, and seed investment company Inserm Transfert Initiative today announced the signing of a four-year scientific collaboration agreement for research and development.

 Downloadpdf

 


Increase font size Default font size Decrease font size